Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Mason

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
BMC Research Notes|January 24, 2024
Utilising electrodermal activity sensor signals to quantify nociceptive response during movement activitiesRebecca I Hamilton, Ashly Alava Garcia, Jake Bowd, et al.
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|May 9, 2015
Osteoclastogenesis-related cytokines and peri-prosthetic osteolysis in revision metal-on-metal total hip replacementsSarah E Eastwood, Alun John, Stephen A Jones, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 10, 2021
A Multi-Step Model of Parkinson's Disease PathogenesisCampbell Le Heron, Michael MacAskill, Deborah Mason, et al.
Exploratory Research in Clinical and Social Pharmacy|September 25, 2024
The evaluation of an osteoporosis medication management service in community pharmacy, a cohort studyJonathan Phuong, Sunny Manon, Rebekah Moles, et al.
European Journal of Neurology|January 11, 2021
Functional neurological disorders presenting as emergencies to secondary careJames Beharry, David Palmer, Teddy Wu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 27, 2013
Assessing possible selection bias in a national voluntary MS longitudinal study in AustraliaBruce V Taylor, Andrew Palmer, Steve Simpson, et al.
Clinical Immunology (Orlando, Fla.)|March 13, 2024
The immune cell transcriptome is modulated by vitamin D<sub>3</sub> supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trialWei Zhen Yeh, Melissa Gresle, Rodney Lea, et al.
Stroke|February 16, 2021
Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic StrokeCathy S Zhong, James Beharry, Daniel Salazar, et al.
Brain : a Journal of Neurology|December 12, 2023
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndromeHelmut Butzkueven, Anne-Louise Ponsonby, Mark S Stein, et al.
NPJ Digital Medicine|July 24, 2025
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical dataAshkan Pirmani, Edward De Brouwer, Ádám Arany, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
BMC Research Notes|January 24, 2024
Utilising electrodermal activity sensor signals to quantify nociceptive response during movement activitiesRebecca I Hamilton, Ashly Alava Garcia, Jake Bowd, et al.
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|May 9, 2015
Osteoclastogenesis-related cytokines and peri-prosthetic osteolysis in revision metal-on-metal total hip replacementsSarah E Eastwood, Alun John, Stephen A Jones, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 10, 2021
A Multi-Step Model of Parkinson's Disease PathogenesisCampbell Le Heron, Michael MacAskill, Deborah Mason, et al.
Exploratory Research in Clinical and Social Pharmacy|September 25, 2024
The evaluation of an osteoporosis medication management service in community pharmacy, a cohort studyJonathan Phuong, Sunny Manon, Rebekah Moles, et al.
European Journal of Neurology|January 11, 2021
Functional neurological disorders presenting as emergencies to secondary careJames Beharry, David Palmer, Teddy Wu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 27, 2013
Assessing possible selection bias in a national voluntary MS longitudinal study in AustraliaBruce V Taylor, Andrew Palmer, Steve Simpson, et al.
Clinical Immunology (Orlando, Fla.)|March 13, 2024
The immune cell transcriptome is modulated by vitamin D<sub>3</sub> supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trialWei Zhen Yeh, Melissa Gresle, Rodney Lea, et al.
Stroke|February 16, 2021
Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic StrokeCathy S Zhong, James Beharry, Daniel Salazar, et al.
Brain : a Journal of Neurology|December 12, 2023
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndromeHelmut Butzkueven, Anne-Louise Ponsonby, Mark S Stein, et al.
NPJ Digital Medicine|July 24, 2025
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical dataAshkan Pirmani, Edward De Brouwer, Ádám Arany, et al.
Pageof 3